Sustainability of EU regulatory system on medicinal products

vrijdag 10 oktober 2014 15:00

In safeguarding the quality, safety and efficacy of medicinal products, the present EU regulatory system has become a time consuming and highly regulated process. This raises questions about the sustainability of the system. Today RIVM published the report entitled Minds Open: sustainability of the European regulatory system for medicinal products, which deals with the four key issues of safety and efficacy, cost, innovation, and availability.